Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
EHop-016
Cat. No.:
OB0225LY-0048
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
EHop-016 is a Cdc42 and Rac1 inhibitor that affects cell signaling pathways.
Synonym:
EHop 016; 1380432-32-5; N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholinopropyl)pyrimidine-2,4-diamine; 4-N-(9-Ethylcarbazol-3-yl)-2-N-(3-morpholin-4-ylpropyl)pyrimidine-2,4-diamine; N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-yl-propyl)-pyrimidine-2,4-diamine
CAS No.:
1380432-32-5
Compound CID:
51031035
Formula:
C25H30N6O
Formula Weight:
430.55
Specification
Relative Density:
1.27 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
EHop-016 is used in neuroscience and oncology research to explore mechanisms of cell movement and migration.
Library Information
Targets:
Rho; Ras
Receptors:
Rac1
Pathways:
GPCR/G protein; Cell cycle/Checkpoint; MAPK
Plate Number:
AOCL-1
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 116.13 mM
